Vibeke Backer, Ulf Sjöbring, Jesper Sonne, Anne Weiss, Morten Hostrup, Helle Krogh Johansen, . . . Morten Otto Alexander Sommer. (2021). A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19. Elsevier.
Chicago Style (17th ed.) CitationVibeke Backer, et al. A Randomized, Double-blind, Placebo-controlled Phase 1 Trial of Inhaled and Intranasal Niclosamide: A Broad Spectrum Antiviral Candidate for Treatment of COVID-19. Elsevier, 2021.
MLA (9th ed.) CitationVibeke Backer, et al. A Randomized, Double-blind, Placebo-controlled Phase 1 Trial of Inhaled and Intranasal Niclosamide: A Broad Spectrum Antiviral Candidate for Treatment of COVID-19. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.